Home
Biomarin Pharmaceutical BMRN spent $420K on lobbying in Q4 2022 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $420,000
- Quarter
- Q4 2022
- Client
- Biomarin Pharmaceutical
- Reported
- 23/01/20
$450K on lobbying in 2022
What else happened in Biomarin Pharmaceutical around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Biomarin Pharmaceutical's other lobbying reports
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$340K
$340K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$30K
$30K
Reported 07/06
for Q2 2017
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$530K
$530K
Reported 04/20
for Q1
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 04/20
for Q1